DXTR's success depends on Europe,..specifically Braun.
thats my WAG. granted ISRG is potentially in the picture but no recent news has surfaced involving them. time will tell ISRG's involvement.
if the corrections on the 5/80 are properly executed there will be no problem.
the 5/80 was beta tested by very prestigious thoracic surgeons and was found to operate flawlessly. so logic tells me that it might be the 6 doctors whom complained might not be using the instrument correctly. this is just a guess. but for it to pass all tests and have 6 doctors complain is concerning but not for a 20% decline in price.
i'll be adding to my collection of DXTR. this is no deterrent...its a buying opp.
invest at your own risk, based on your own due diligence, at your own risk tolerance